FDA-approved since 2005, GLP-1 agonists, including exenatide and newer formulations, have shown promise in improving glycemic control and aiding in sustained weight management (7)
Fibre also slows digestion, helping to extend the release of GLP-1 over a longer period, supporting satiety and stable blood sugar levels
For mothers who have been researching tirzepatide results , this data provides important context for informed conversations with their healthcare providers
However, like semaglutide, retatrutide's effect on stomach emptying lessens over time, which might need a break from the drug to restore its effectiveness
Under conditions of reduced portal insulin-to-glucagon ratio, lipolysis increases in adipose tissue and releases non-esterifed fatty acids which are converted to ketone bodies in the liver through mitochondrial beta oxidation and ketogenesis [25], resulting in a metabolic condition resembling a prolonged fast [26]